» Articles » PMID: 33657416

Development, Maturation, and Maintenance of Human Prostate Inferred from Somatic Mutations

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2021 Mar 3
PMID 33657416
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Clonal dynamics and mutation burden in healthy human prostate epithelium are relevant to prostate cancer. We sequenced whole genomes from 409 microdissections of normal prostate epithelium across 8 donors, using phylogenetic reconstruction with spatial mapping in a 59-year-old man's prostate to reconstruct tissue dynamics across the lifespan. Somatic mutations accumulate steadily at ∼16 mutations/year/clone, with higher rates in peripheral than peri-urethral regions. The 24-30 independent glandular subunits are established as rudimentary ductal structures during fetal development by 5-10 embryonic cells each. Puberty induces formation of further side and terminal branches by local stem cells disseminated throughout the rudimentary ducts during development. During adult tissue maintenance, clonal expansions have limited geographic scope and minimal migration. Driver mutations are rare in aging prostate epithelium, but the one driver we did observe generated a sizable intraepithelial clonal expansion. Leveraging unbiased clock-like mutations, we define prostate stem cell dynamics through fetal development, puberty, and aging.

Citing Articles

Prolonged persistence of mutagenic DNA lesions in somatic cells.

Spencer Chapman M, Mitchell E, Yoshida K, Williams N, Fabre M, Ranzoni A Nature. 2025; 638(8051):729-738.

PMID: 39814886 PMC: 11839459. DOI: 10.1038/s41586-024-08423-8.


Clonal expansion in normal tissues.

Maeda H, Kakiuchi N Cancer Sci. 2024; 115(7):2117-2124.

PMID: 38623936 PMC: 11247609. DOI: 10.1111/cas.16183.


Somatic mutations in aging and disease.

Ren P, Zhang J, Vijg J Geroscience. 2024; 46(5):5171-5189.

PMID: 38488948 PMC: 11336144. DOI: 10.1007/s11357-024-01113-3.


Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer.

Chae J, Jung S, Choi E, Kim J, Kim N, Moon S Exp Mol Med. 2024; 56(1):168-176.

PMID: 38172600 PMC: 10834420. DOI: 10.1038/s12276-023-01140-8.


Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs.

Ng A, Chan D Oncogene. 2023; 42(37):2713-2724.

PMID: 37573406 PMC: 10491491. DOI: 10.1038/s41388-023-02802-7.


References
1.
Wang Y, Hayward S, Cao M, Thayer K, Cunha G . Cell differentiation lineage in the prostate. Differentiation. 2002; 68(4-5):270-9. DOI: 10.1046/j.1432-0436.2001.680414.x. View

2.
Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S . Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015; 348(6237):880-6. PMC: 4471149. DOI: 10.1126/science.aaa6806. View

3.
Brunner S, Roberts N, Wylie L, Moore L, Aitken S, Davies S . Somatic mutations and clonal dynamics in healthy and cirrhotic human liver. Nature. 2019; 574(7779):538-542. PMC: 6837891. DOI: 10.1038/s41586-019-1670-9. View

4.
Ousset M, Van Keymeulen A, Bouvencourt G, Sharma N, Achouri Y, Simons B . Multipotent and unipotent progenitors contribute to prostate postnatal development. Nat Cell Biol. 2012; 14(11):1131-8. DOI: 10.1038/ncb2600. View

5.
Alexandrov L, Kim J, Haradhvala N, Huang M, Ng A, Wu Y . The repertoire of mutational signatures in human cancer. Nature. 2020; 578(7793):94-101. PMC: 7054213. DOI: 10.1038/s41586-020-1943-3. View